Sensei Biotherapeutics Inc reports results for the quarter ended in March - Earnings Summary

Faeth Therapeutics,

12/05/2021 16:52

* Sensei Biotherapeutics Inc  SNSE.OQ  reported a quarterly
adjusted loss of 42 cents​​ per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 30 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Sensei Biotherapeutics Inc's reported EPS for the quarter was
a loss of 42 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Sensei Biotherapeutics Inc shares had fallen by 30.1% this
quarter.
* The company reported a quarterly loss of $7.97 million.
* Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $28.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 12 at 03:52 p.m. GMT.
​All figures in US dollars